<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Fusion nanoparticle systems &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/fusion-nanoparticle-systems/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 19 Sep 2025 11:54:15 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Fusion nanoparticle systems &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Novel Nanoparticle System Boosts Cancer Treatment Efficacy</title>
		<link>https://bioengineer.org/novel-nanoparticle-system-boosts-cancer-treatment-efficacy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 19 Sep 2025 11:53:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Docetaxel-loaded liposomes]]></category>
		<category><![CDATA[Enhanced chemotherapy efficacy]]></category>
		<category><![CDATA[Extracellular vesicles drug delivery]]></category>
		<category><![CDATA[Fusion nanoparticle systems]]></category>
		<category><![CDATA[Targeted cancer nanotherapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/novel-nanoparticle-system-boosts-cancer-treatment-efficacy/</guid>

					<description><![CDATA[In a groundbreaking study that blurs the lines between nanotechnology and cancer therapeutics, researchers have developed an innovative fusion nanoparticle system designed to enhance the efficacy of anticancer drugs. This emerging strategy involves the combination of extracellular vesicles (EVs) and docetaxel-loaded liposomes, a novel approach that promises to transform the landscape of cancer treatment. The [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">270669</post-id>	</item>
	</channel>
</rss>
